Atul Bedi

City:

Timonium, Maryland

Country:

United States

Published Applications:

Last publication date:

2025-01-09

Top Assignees for applications by Atul Bedi

The entities that hold a legal rights for patent applications filed by inventor Bedi Atul:

THE JOHNS HOPKINS UNIVERSITY 8 Baltimore, MD United States

Recent patent applications by Bedi Atul

Atul Bedi from Timonium, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2025-01-09

US20250009772A1

Human necessities

Compositions and methods for targeted immunomodulatory antibodies and fusion proteins

#2 | 2022-06-30

US20220204628A1

Chemistry; metallurgy

COMPOSITIONS AND METHODS FOR TARGETED IMMUNOMODULATORY ANTIBODIES AND FUSION PROTEINS

#3 | 2021-04-15

US20210107969A1

Chemistry; metallurgy

MOLECULES, COMPOSITIONS AND METHODS FOR TREATMENT OF CANCER

#4 | 2020-04-16

US20200115455A1

Chemistry; metallurgy

Compositions and methods for targeted immunomodulatory antibodies and fusion proteins

#5 | 2017-06-08

US20170158770A1

Chemistry; metallurgy

Compositions and methods for targeted immunomodulatory antibodies and fusion proteins

#6 | 2016-11-24

US20160340430A1

Chemistry; metallurgy

Compositions and methods for targeted immunomodulatory antibodies and fusion proteins

#7 | 2015-07-02

US20150183881A1

Chemistry; metallurgy

Compositions and methods for targeted immunomodulatory antibodies and fusion proteins

#8 | 2013-02-14

US20130039911A1

Chemistry; metallurgy

Compositions and methods for targeted immunomodulatory antibodies and fusion proteins

#9 | 2009-05-14

US20090123467A1

Human necessities

Polypeptide-Nucleic Acid Conjugate for Immunoprophylaxis or Immunotherapy for Neoplastic or Infectious Disorders

#10 | 2007-09-13

US20070212337A1

Human necessities

Polypeptide-nucleic acid conjugate for immunoprophylaxis or immunotherapy for neoplastic or infectious disorders

InventorID:

89184 ⎘